醫療機器人市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球醫療機器人市場規模將達到 128 億美元，預計 2025 年至 2034 年期間複合年成長率將達到 16.6%。 這一顯著成長得益於醫療保健領域自動化程度的不斷提高、政府和私人組織的大量投資以及微創手術的日益普及。由於醫療保健產業面臨巨大的壓力，需要應對成本不斷上漲、勞動力短缺和精準度要求等挑戰，醫療機器人已成為改變遊戲規則的解決方案。這些先進的系統不僅最佳化了資源利用率，而且還提高了程序的準確性，減少了錯誤並改善了患者的治療效果。它們的應用範圍從複雜的手術到復健和病人監測，使它們在整個醫療保健環境中不可或缺。人工智慧機器人和 3D 成像等技術進步進一步推動了市場發展，徹底改變了醫療保健提供者提供護理的方式。

醫療機器人正在透過解決關鍵的效率低下問題並提供可靠、經濟高效的解決方案來改變醫療保健。這些系統能夠提高手術精度、一致性復健護理和即時患者監測，從而改善臨床結果並提高患者滿意度。它們在減少人為錯誤、簡化操作和自主完成任務方面特別有效。機器人技術的日益普及反映了醫療保健產業致力於利用創新來提供更好的醫療服務。隨著醫院和診所尋求提高效率和病患體驗，全球對醫療機器人的需求正在激增。

市場分為幾個主要部分，包括遠距醫療機器人、藥房和醫院自動化機器人、手術機器人、復健機器人和非侵入性放射外科機器人。其中，手術機器人在2024年佔據市場主導地位，創造了81億美元的收入。它們能夠提供更安全、更有效的結果，這使得它們在微創手術中成為不可或缺的一部分。這些機器人以其無與倫比的精度、減少的失血量和更快的恢復時間而聞名，在世界各地的手術室中得到廣泛應用。

醫療機器人的應用涉及多個領域，包括腹腔鏡手術、骨科手術、神經病學、心臟病學、藥房運作和物理復健。腹腔鏡系統在 2024 年引領市場，貢獻 43 億美元的收入。人工智慧引導、3D 成像和即時分析等技術創新使外科醫生能夠以最小的組織損傷執行複雜的手術，從而推動了對這些系統的需求增加。

2024年北美醫療機器人市場價值為78億美元，佔全球市場的很大佔有率。該地區的主導地位歸因於高醫療支出、支持性政策以及對機器人技術的更高認知。肥胖症和心血管疾病等慢性病的流行加劇了對機器人輔助手術（尤其是腹腔鏡手術）的需求。這一趨勢促使該地區的醫療機構大力投資機器人系統，進一步推動市場成長。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 機器人輔助手術的廣泛健康保險計劃
    • 外科手術數量增加
    • 手術機器人的普及率很高
    • 技術進步
  • 產業陷阱與挑戰
    • 機器人系統成本高
    • 缺乏意識
    • 嚴格的法規核准
• 成長潛力分析
• 監管格局
  • 美國
  • 歐洲
• 技術格局
• 未來市場趨勢
• 差距分析
• 價值鏈分析
• 波特的分析
• PESTEL 分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第 5 章：市場估計與預測：按產品類型，2021 年至 2034 年

• 主要趨勢
• 手術機器人
• 藥局和醫院自動化機器人
• 復健機器人
• 遠距醫療機器人
• 非侵入性放射外科機器人

第 6 章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 腹腔鏡
• 骨科
• 神經病學
• 心臟病學
• 藥房應用
• 物理復健
• 其他應用

第 7 章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 門診手術中心 (ASC)
• 復健中心
• 其他最終用途

第 8 章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• ACCURAY
• Aethon
• ARxIUM
• Capsa Healthcare
• Globus Medical
• Hocoma
• Intuitive Surgical
• Johnson & Johnson
• Medtronic
• Omnicell
• Reinshaw
• Smith & Nephew
• Stryker Corporation
• THINK Surgical
• Zimmer Biomet

The Global Medical Robots Market reached USD 12.8 billion in 2024 and is projected to expand at a robust CAGR of 16.6% from 2025 to 2034. This remarkable growth is fueled by the increasing integration of automation in healthcare, significant investments from governments and private organizations, and the rising popularity of minimally invasive procedures. With the healthcare sector under immense pressure to address challenges like escalating costs, workforce shortages, and the demand for precision, medical robots have emerged as a game-changing solution. These advanced systems not only optimize resource utilization but also enhance procedural accuracy, reduce errors, and improve patient outcomes. Their applications range from complex surgeries to rehabilitation and patient monitoring, making them indispensable across healthcare settings. The market is further driven by technological advancements, such as AI-powered robotics and 3D imaging, revolutionizing how healthcare providers deliver care.

Medical robots are transforming healthcare by addressing critical inefficiencies and offering reliable, cost-effective solutions. These systems enable enhanced surgical precision, consistent rehabilitation care, and real-time patient monitoring, leading to improved clinical outcomes and higher patient satisfaction. They are particularly effective in reducing human errors, streamlining operations, and delivering tasks autonomously. The growing adoption of robotic technologies reflects the healthcare industry's commitment to leveraging innovation for better care delivery. As hospitals and clinics seek to improve efficiency and patient experience, the demand for medical robots is surging globally.

The market is categorized into key segments, including telemedicine robots, pharmacy and hospital automation robots, surgical robots, rehabilitation robots, and non-invasive radiosurgery robots. Among these, surgical robots dominated the market in 2024, generating USD 8.1 billion in revenue. Their ability to deliver safer and more efficient outcomes has made them indispensable in minimally invasive procedures. These robots are recognized for their unmatched precision, reduced blood loss, and faster recovery times, leading to their widespread adoption in operating rooms worldwide.

Applications of medical robots span diverse domains, including laparoscopic surgeries, orthopedic procedures, neurology, cardiology, pharmacy operations, and physical rehabilitation. Laparoscopic systems led the market in 2024, contributing USD 4.3 billion in revenue. Technological innovations like AI-driven guidance, 3D imaging, and real-time analytics empower surgeons to perform complex procedures with minimal tissue damage, driving increased demand for these systems.

North America medical robots market generated USD 7.8 billion in 2024, accounting for a substantial share of the global market. The region's dominance is attributed to high healthcare spending, supportive policies, and greater awareness of robotic technologies. The prevalence of chronic conditions, such as obesity and cardiovascular diseases, has heightened the need for robotic-assisted surgeries, particularly laparoscopic procedures. This trend has prompted healthcare facilities across the region to invest heavily in robotic systems, further fueling market growth.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Broad health coverage plans for robot-assisted surgeries
    • 3.2.1.2 Rise in the number of surgical procedures
    • 3.2.1.3 High adoption of surgical robots
    • 3.2.1.4 Technological advancements
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of robotic systems
    • 3.2.2.2 Lack of awareness
    • 3.2.2.3 Stringent regulatory approval
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Value chain analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Surgical robots
• 5.3 Pharmacy and hospital automation robots
• 5.4 Rehabilitation robots
• 5.5 Telemedicine robots
• 5.6 Non-invasive radiosurgery robots

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Laparoscopic
• 6.3 Orthopedic
• 6.4 Neurology
• 6.5 Cardiology
• 6.6 Pharmacy applications
• 6.7 Physical rehabilitation
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers (ASCs)
• 7.4 Rehabilitation centers
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 ACCURAY
• 9.2 Aethon
• 9.3 ARxIUM
• 9.4 Capsa Healthcare
• 9.5 Globus Medical
• 9.6 Hocoma
• 9.7 Intuitive Surgical
• 9.8 Johnson & Johnson
• 9.9 Medtronic
• 9.10 Omnicell
• 9.11 Reinshaw
• 9.12 Smith & Nephew
• 9.13 Stryker Corporation
• 9.14 THINK Surgical
• 9.15 Zimmer Biomet